Developing Body-Components-Based Theranostic Nanoparticles for Targeting Ovarian Cancer

Developing Body-Components-Based Theranostic Nanoparticles for Targeting Ovarian Cancer

Ovarian cancer mortality is the highest among gynecologic malignancies. Hence, the major challenges are early diagnosis and efficient targeted therapy. Herein, we devised model theranostic nanoparticles (NPs) for combined diagnostics and delivery of chemotherapeutics, targeted to ovarian cancer cell...

Full description

Bibliographic Details
Main Authors: Ravit Edelman, Yehuda G. Assaraf, Anton Slavkin, Tamar Dolev, Tal Shahar, Yoav D. Livney
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:Pharmaceutics
Subjects:
hyaluronic acid
serum albumin
Maillard conjugates
theranostic nanoparticles
CD44-targeted chemotherapy
ovarian cancer
Online Access:https://www.mdpi.com/1999-4923/11/5/216

Internet

https://www.mdpi.com/1999-4923/11/5/216

Similar Items